508 related articles for article (PubMed ID: 14607752)
1. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
[TBL] [Abstract][Full Text] [Related]
2. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
4. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
6. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on GST-Pi genetic polymorphism in children with acute leukemia].
Yuan XJ; Gu LJ; Xue HL; Tang JY; Zhao JC; Chen J; Wang YP; Chen J; Pan C; Song DL
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(21):1863-6. PubMed ID: 14642067
[TBL] [Abstract][Full Text] [Related]
8. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
Marino S; Verzegnassi F; Tamaro P; Stocco G; Bartoli F; Decorti G; Rabusin M
Pediatr Blood Cancer; 2009 Dec; 53(6):984-91. PubMed ID: 19621425
[TBL] [Abstract][Full Text] [Related]
9. Expression of mu class glutathione S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia.
Hall AG; Autzen P; Cattan AR; Malcolm AJ; Cole M; Kernahan J; Reid MM
Cancer Res; 1994 Oct; 54(20):5251-4. PubMed ID: 7923148
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
[TBL] [Abstract][Full Text] [Related]
11. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia.
Balta G; Yuksek N; Ozyurek E; Ertem U; Hicsonmez G; Altay C; Gurgey A
Am J Hematol; 2003 Jul; 73(3):154-60. PubMed ID: 12827651
[TBL] [Abstract][Full Text] [Related]
12. Gene dose effects of GSTM1, GSTT1 and GSTP1 polymorphisms on outcome in childhood acute lymphoblastic leukemia.
Borst L; Buchard A; Rosthøj S; Wesolowska A; Wehner PS; Wesenberg F; Dalhoff K; Schmiegelow K
J Pediatr Hematol Oncol; 2012 Jan; 34(1):38-42. PubMed ID: 22215096
[TBL] [Abstract][Full Text] [Related]
13. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
14. [The effects of glutathione S-transferase (GSTT1 and GSTM1) genes polymorphisms on treatment efficacy and prognosis of acute myeloid leukemia].
Zhang Y; Yang L; Li R; Zhang L; Zhang MR; Xiao ZJ
Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):213-6. PubMed ID: 16624155
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study.
Stanulla M; Schrappe M; Brechlin AM; Zimmermann M; Welte K
Blood; 2000 Feb; 95(4):1222-8. PubMed ID: 10666194
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy.
Naoe T; Tagawa Y; Kiyoi H; Kodera Y; Miyawaki S; Asou N; Kuriyama K; Kusumoto S; Shimazaki C; Saito K; Akiyama H; Motoji T; Nishimura M; Shinagawa K; Ueda R; Saito H; Ohno R
Leukemia; 2002 Feb; 16(2):203-8. PubMed ID: 11840286
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms within glutathione S-transferase genes in pediatric non-Hodgkin's lymphoma.
Dieckvoss BO; Stanulla M; Schrappe M; Beier R; Zimmermann M; Welte K; Reiter A
Haematologica; 2002 Jul; 87(7):709-13; discussion 713. PubMed ID: 12091121
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
Wang YR; Jin RM; Xu JW; Xiao Y; Zhou DF; Zhang ZQ
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
[TBL] [Abstract][Full Text] [Related]
19. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
[TBL] [Abstract][Full Text] [Related]
20. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
